Advertisement

Picture Berlin Partner Top News CRIPSR Repairs Immune Cells 650x100px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1054 | Ordered by Source (ascending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Inova Software S.A.S.. (7/1/21). "Press Release: Carlyle Partners with Inova. Growth Equity Transaction to Support Inova’s Ambition to Become the Leading Platform for Life Science Collaborations". Lyon. 2021-07-01
Inova Software S.A.S.. (9/27/18). "Press Release: Inova Software Secures Additional Funding from Its Founders and NextStage AM to Support Its Strong Growth". New York, NY. 2018-09-27
Inpart S.A.S.. (2/29/24). "Press Release: Inpart and Evaluate Announce Strategic Partnership to Optimize Biopharma Dealmaking". Lyon. 2024-02-29
IntegraGen S.A.. (1/9/17). "Press Release: IntegraGen Reports Sharp Increase in Sales during 2016". Évry. 2017-01-09
IntegraGen S.A.. (11/12/18). "Press Release: IntegraGen Announces Collaboration with Google Cloud to Offer Large Scale Genomic Analysis Tools for Clinicians and Medical Researchers". Paris. 2018-11-12
IntegraGen S.A.. (2/3/17). "Press Release: IntegraGen Announces Successful Completion of a € 3.7 Million Capital Increase". Évry. 2017-02-03
IntegraGen S.A.. (3/8/17). "Press Release: Laboratoire Cerba Enters into Licensing Agreement with IntegraGen for the Commercialization of miR-31-3p Tumor Expression Test in France, Benelux, Middle East and Africa". Saint-Ouen l’Aumône & Évry. 2017-03-08
IntegraGen S.A.. (4/21/17). "Press Release: IntegraGen Announces 2016 Annual Results". Évry. 2017-04-21
IntegraGen S.A.. (9/7/17). "Press Release: IntegraGen Announces CE-IVD Marking of miRpredX 31-3p Kit which Predicts Patient Response to anti-EGFR Therapy in RAS Wild-Type Metastatic Colorectal Cancer". Évry. 2017-09-07
Ipsen S.A.. (1/12/18). "Press Release: Ipsen Appoints Richard Paulson Executive Vice-President and Chief Executive Officer of Ipsen North America". Paris. 2018-01-12
Ipsen S.A.. (1/24/20). "Press Release: Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria". Paris. 2020-01-24
Ipsen S.A.. (1/31/17). "Press Release: Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma". Paris. 2017-01-31
Ipsen S.A.. (1/9/17). "Press Release: Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals". Paris. 2017-01-09
Ipsen S.A.. (1/9/23). "Press Release: Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases". Paris & Boston, MA. 2023-01-09
Ipsen S.A.. (11/15/18). "Press Release: European Commission Approves Ipsen’s Cabometyx (cabozantinib) for the Treatment of Hepatocellular Carcinoma in Adults Previously Treated with Sorafenib". Paris. 2018-11-15
Ipsen S.A.. (12/18/19). "Press Release: Ipsen Announces Departure of David Meek as Chief Executive Officer". Paris. 2019-12-18
Ipsen S.A.. (2/13/17). "Press Release: Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi". Paris. 2017-02-13
Ipsen S.A.. (2/23/17). "Press Release: Ipsen Delivers Strong 2016 Results and Expects Further Sales Growth and Margin Enhancement for 2017". Paris. 2017-02-23
Ipsen S.A.. (6/27/22). "Press Release: Ipsen to Acquire Epizyme, Expanding Its Portfolio in Oncology". Paris & Cambridge, MA. 2022-06-27
Ipsen S.A.. (9/25/20). "Press Release: Ipsen Appoints Philippe Lopes-Fernandes as Executive Vice President, Chief Business Officer". Paris. 2020-09-25
Jeito Capital. (1/15/20). "Press Release: Rafaèle Tordjman Launches Jeito Capital, a New Private Equity Company Dedicated to Biotech-biopharmaceuticals, and Announces the Closing of Jeito I at €200 Million". Paris. 2020-01-15
Jeito Capital. (1/26/21). "Press Release: First Year-in-Review – Jeito Capital Confirms Strength of Its Investment Model and 2021 Ambitions with more Deals and Significant Capital". Paris. 2021-01-26
Jeito Capital. (11/13/20). "Press Release: Sanofi Selects Jeito Capital as Its First Investment into a Private French-based Fund". Paris. 2020-11-13
Jeito Capital. (12/14/20). "Press Release: Jeito Capital Leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and Leader in Rare Skeletal Disorders". Paris. 2020-12-14
Jeito Capital. (2/17/22). "Press Release: Jeito Capital Announces the Appointments of Dr Andreas Wallnöfer as Partner Investor and Isabelle Meyrier as Head of Legal". Paris. 2022-02-17
Jeito Capital. (2/22/22). "Press Release: Jeito Capital Co-leads $65 Million Series A Financing in EyeBio". Paris. 2022-02-22
Jeito Capital. (5/27/21). "Press Release: Jeito Capital Leads Oversubscribed $92 million Series C Financing Round in Pulmocide". Paris. 2021-05-27
Jeito Capital. (6/15/21). "Press Release: Jeito Capital Becomes Key Investor in Alentis Therapeutics as Part of $67 Million Series B Financing Round". Paris. 2021-06-15
Jeito Capital. (7/28/21). "Press Release: Jeito Capital’s Dr. Rafaèle Tordjman Appointed to Promote the French Biotech Ecosystem". Paris. 2021-07-28
Jeito Capital. (9/20/21). "Press Release: Jeito Capital Becomes Key Player in the Financing of Life Sciences in Europe with the Closing of Jeito I at €534 million ($630 million)". Paris. 2021-09-20
Keensight Capital. (7/23/19). "Press Release: Keensight Capital Acquires 3P Biopharmaceuticals to Accelerate Its Global Growth Strategy". Paris. 2019-07-23
Keranova S.A.. (9/10/19). "Press Release: Keranova Raises €24m in Second Round of Financing". Saint-Etienne & Lyon. 2019-09-10
Kurma Partners. (11/9/20). "Press Release: Kurma Partners Strengthens Its Teams and Promotes Its Talents". Paris. 2020-11-09
Kurma Partners. (12/14/18). "Press Release: Kurma Partners Announces the First Closing of Kurma Biofund III". Paris. 2018-12-14
Kurma Partners. (3/7/22). "Press Release: Kurma Partners Targets €250 Million for its First Growth Opportunities Fund". Paris. 2022-03-07
Kurma Partners. (4/13/21). "Press Release: Jean-François Rivassou Joins Kurma Partners as Partner". Paris. 2021-04-13
Kurma Partners. (4/29/20). "Press Release: Kurma Partners Announces the Final Closing of Its Kurma Biofund III Fund at €160 Million". Paris. 2020-04-29
Kurma Partners. (9/29/20). "Press Release: Kurma Partners Announces the First Closing of Kurma Diagnostics 2 (KDx2) Fund at €50 Million". Paris. 2020-09-29
Lauxera Capital Partners. (9/12/23). "Press Release: Lauxera Capital Partners Invests €17 Million in Swedish Regenerative Medicine Leader BioLamina AB". Paris & San Francisco, CA. 2023-09-12
Leman Instruments SAS. (6/9/17). "Press Release: Leman Instruments Introduces New Family of High Purity Oxygen Generators. OXYSTATION 20 LC and OXYSTATION 40LC Instruments Now Available". Archamps. 2017-06-09
Lesaffre & Cie.. (9/7/22). "Press Release: Lesaffre Acquires Recombia Biosciences, a Biotechnology Company Specialized in High-throughput Genome Editing and Synthetic Biology". Paris & San Francisco, CA. 2022-09-07
Leti. (11/30/17). "Press Release: Leti Develops Meg Technology To Improve Diagnosis Of Epilepsy and Guide Surgeons During Brain Surgery". 2017-11-30
Leti. (12/4/17). "Press Release: Leti Researcher Reappointed Head of the European Technology Platform for Nanomedicine". 2017-12-04
Leti. (12/6/17). "Press Release: Innovation in the Diagnosis of Breast Cancer". 2017-12-06
LimFlow S.A.. (11/1/23). "Press Release: LimFlow Announces Agreement to Be Acquired by Inari Medical". Paris & San José, CA. 2023-11-01
LimFlow S.A.. (4/6/22). "Press Release: LimFlow Raises $40 Million (€36 Million) in Series D Financing". Paris. 2022-04-06
LNC Therapeutics. (4/15/20). "Press Release: LNC Therapeutics Announces the Acquisition of an Exclusive Worldwide Licence on the First Patent related to Christensenella’s Therapeutic Applications in Mood Disorders". Bordeaux. 2020-04-15
LNC Therapeutics. (4/17/18). "Press Release: LNC Therapeutics Appoints New CEO, Dr. Georges Rawadi, and Accelerates Development in Microbiome Research". Bordeaux. 2018-04-17
LNC Therapeutics. (9/27/17). "Press Release: LNC Therapeutics Raises € 6.5 Million and Reinforces Its R&D in the Microbiota Field". Bordeaux. 2017-09-27
LNC Therapeutics. (9/5/19). "Press Release: LNC Therapeutics Raises €6.2 Million for the Clinical Development of New Generation Drugs Based on the Gut Genome". 2019-09-05
LXRepair S.A.S.. (1/20/21). "Press Release: Stéphane Altaba Is Appointed CEO of the Start-up Company LXRepair". Paris. 2021-01-20
Lys Therapeutics S.A.S.. (11/14/22). "Press Release: Lys Therapeutics Announces a Seed Round of 5.5 Million Euros to Prepare Future Clinical Studies for Its First-in-class Monoclonal Antibody targeting neurovascular and neurodegenerative disorders". Lyon 2022-11-14
Lys Therapeutics S.A.S.. (3/15/23). "Press Release: Lys Therapeutics Secures Funding from The Michael J. Fox Foundation to Accelerate the Development of Its Drug Candidate in Parkinson’s Disease". Lyon & Caen. 2023-03-15
Lysogene S.A.. (1/18/17). "Press Release: Lysogene Receives Rare Pediatric Disease Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA. 2017-01-18
Lysogene S.A.. (1/25/17). "Press Release: Lysogene Launches Its IPO on Euronext’s Regulated Market in Paris". 2017-01-25
Lysogene S.A.. (10/17/19). "Press Release: Lysogene Appoints Mr. Stéphane Durant des Aulnois as Chief Financial Officer". Paris. 2019-10-17
Lysogene S.A.. (2/2/17). "Press Release: Lysogene Receives Orphan Drug Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris. 2017-02-02
Lysogene S.A.. (2/21/17). "Press Release: Lysogene Receives Orphan Drug Designation from EMA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA. 2017-02-21
Lysogene S.A.. (2/7/17). "Press Release: Lysogene Announces Its Successful IPO on Euronext Paris with nearly €22.6m Raised [Not for US, CA, AU, JP]". Paris. 2017-02-07
Lysogene S.A.. (3/12/20). "Press Release: Lysogene Completes €7.7 Million Capital Increase in a Placement Led by Leading Healthcare Investor OrbiMed and Lysogene Shareholder and Partner Sarepta [Not for US, CA, AU or JP]". Paris. 2020-03-12
Lysogene S.A.. (4/20/17). "Press Release: Lysogene Announces Selection of MRI Interventions’ SmartFlow Cannula for Phase II/III Clinical Study in MPS IIIA". Paris & Cambridge, MA. 2017-04-20
Lysogene S.A.. (4/21/17). "Press Release: 2016 Annual Results". Paris & Cambridge, MA. 2017-04-21
Lysogene S.A.. (7/1/20). "Press Release: Lysogene Announces a Research Collaboration with the Weizmann Institute of Science". Paris. 2020-07-01
L’Oréal S.A.. (12/5/18). "Press Release: L'Oréal Creates a Corporate Venture Capital Fund Dedicated to Accompanying Innovative Startups". Clichy. 2018-12-05
MaaT Pharma. (10/15/21). "Press Release: MaaT Pharma Launches Its Initial Public Offering on the Regulated Market of Euronext in Paris [ Not for US, CA, AU, JP or RK ]". Lyon. 2021-10-15
MaaT Pharma. (12/1/20). "Press Release: MaaT Pharma Announces Series B Extension and Final Closing with Total of €25 Million ($29.5 Million)". Lyon. 2020-12-01
MaaT Pharma. (2/5/20). "Press Release: MaaT Pharma Announces €18 Million Series B Financing Round to Support Further Clinical Development of Microbiome Biotherapeutics". Lyon. 2020-02-05
MaaT Pharma. (5/28/20). "Press Release: MaaT Pharma Appoints Savita Bernal as Chief Business Officer". Lyon. 2020-05-28
MaaT Pharma. (6/21/23). "Press Release: MaaT Pharma Announces New Appointments to the Board and Executive Team". Lyon. 2023-06-21
Mablink Bioscience S.A.S.. (10/14/22). "Press Release: Mablink Bioscience Announces a €31 Million Series A Funding Round Led by Sofinnova Partners and Mérieux Equity Partners". Lyon. 2022-10-14
Mablink Bioscience S.A.S.. (10/18/23). "Press Release: Mablink Bioscience Enters an Agreement to be Acquired by Lilly". Lyon. 2023-10-18
Mablink Bioscience S.A.S.. (10/21/21). "Press Release: Mablink Bioscience and Emergence Therapeutics Enter into a Licensing Agreement to Develop Antibody Drug Conjugate as a Potential Cancer Therapy". Lyon & Duisburg. 2021-10-21
Mablink Bioscience S.A.S.. (4/27/21). "Press Release: Mablink Bioscience, the Next Generation ADC Company, Raises €4 Million from a Syndicate of Private Investors". Lyon. 2021-04-27
Magnisense SE. (10/24/18). "Press Release: Magnisense Successfully Raises € 5 Nillion to Boost the Commercial Development of Its MiAG Emergency Diagnostic Tests for Heart Diseases". Paris. 2018-10-24
McDermott Will & Emery. (1/6/17). "Press Release: McDermott Will & Emery Advised Servier in Its License Option Agreement with OSE Immunotherapeutics". Paris. 2017-01-06
McDermott Will & Emery. (1/9/17). "Press Release: McDermott Will & Emery Advised Servier in Its Strategic Immuno-oncology Co-development Alliance with Pieris Pharmaceuticals". Paris. 2017-01-09
MedDay Pharmaceuticals S.A.S.. (3/10/20). "Press Release: MedDay Reports Top-line Data from Phase III Trial »SPI2« for Treatment of Progressive Forms of Multiple Sclerosis". Paris. 2020-03-10
Median Technologies S.A.. (12/14/23). "Press Release: Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine". Sophia Antipolis & Saclay. 2023-12-14
Medicen Paris Region. (4/20/20). "Press Release: Medicen Paris Region Appoints Jessica Leygues as CEO". Paris. 2020-04-20
Medicen Paris Region. (5/23/17). "Press Release: French Tech Tour Healthcare Israel. Seven Start-ups Assess their Business Potential with Business France, Bpifrance and Medicen Paris Region". Paris. 2017-05-23
Medicen Paris Region. (6/14/18). "Press Release: Medicen Paris Region Appoints Stéphane Roques as CEO". Paris. 2018-06-14
Medicen Paris Region. (9/7/17). "Press Release: BioWin and Medicen Focus on Developing Medical Imaging and Digital Health in Europe". Gosselies & Paris. 2017-09-07
Medigene AG. (4/28/17). "Press Release: Medigene Announces Participation at Six International Conferences". Planegg. 2017-04-28
MedinCell S.A.. (11/28/19). "Press Release: MedinCell Receives $19 Million Grant for Its mdc-WWM Program". Montpellier. 2019-11-28
MedinCell S.A.. (11/30/22). "Press Release: Additional US$ 4 Million Received for Next Development Steps of MedinCell’s 6-month Active Injectable Bioresorbable Subcutaneous Contraceptive". Montpellier. 2022-11-30
MedinCell S.A.. (2/11/21). "Press Release: Tremendous Success for MedinCell’s €30 Million Capital Increase for Qualified Investors". Montpellier. 2021-02-11
MedinCell S.A.. (3/25/20). "Press Release: MedinCell Receives $ 6.4 Million Grant from Unitaid to Fight Malaria". Montpellier. 2020-03-25
MedinCell S.A.. (5/27/20). "Press Release: MedinCell Secures €10.9 Million Non-Dilutive Financing". Montpellier. 2020-05-27
MedinCell S.A.. (6/16/20). "Press Release: MedinCell Announces the Great Success of Its Capital Increase and Raises 15.6 M€ [Not for publication nor to distribution in the United States, Canada, Japan or Australia]". Montpellier. 2020-06-16
Meiogenix S.A.S.. (12/14/21). "Press Release: Meiogenix Announces $13 Million Series A Financing Round Led by Sofinnova Partners". Paris. 2021-12-14
Meletios Therapeutics S.A.S.. (2/28/22). "Press Release: Meletios Therapeutics Signs an Exclusive License Agreement with the Institut Pasteur for the Development of a New Class of Antivirals". Paris. 2022-02-28
Meletios Therapeutics S.A.S.. (8/30/21). "Press Release: Meletios Therapeutics Raises €3.8 Million for the Development of a New Generation of Antiviral Treatments". Paris. 2021-08-30
Mérieux Equity Partners S.A.S.. (1/8/20). "Press Release: Mérieux Equity Partners Successfully Completes the Fundraising of Mérieux Participations 3". Lyon. 2020-01-08
Mérieux Equity Partners S.A.S.. (12/8/20). "Press Release: Cell-Easy Announces the Completion of a Financing Round to Accelerate Its Growth Trajectory in the Cell Therapy Sector, With Merieux Equity Partners as Lead Investor and Reference Shareholder". T 2020-12-08
Metafora Biosystems S.A.S.. (6/11/18). "Press Release: Metafora Biosystems Receives €3.2 Million from European Commission’s H2020 SME Instrument Program". Paris. 2018-06-11
Micropep Technologies S.A.S.. (3/6/18). "Press Release: Micropep Technologies Completes a €4M Seed Round to Boost the Development of Its Unique Discovery Engine". Toulouse. 2018-03-06
Micropep Technologies S.A.S.. (6/27/22). "Press Release: Micropep, Ag-Biotech innovator, Raises €8.75 Million from Global Syndicate to Bring Ground-breaking and Cost-effective Alternatives to Conventional Crop Protection Products to Market". Toulouse. 2022-06-27
Micropep Technologies S.A.S.. (7/8/21). "Press Release: Micropep Raises EUR 8.5M (USD 10M) in Oversubscribed Series A Financing to Develop Innovative Small Peptide Solutions for Agriculture". Toulouse. 2021-07-08
Microphyt S.A.. (7/30/18). "Press Release: Microphyt Is Strengthening Its Teams to Accelerate the Commercialization of Its Natural Active Ingredients Derived from Microalgae". 2018-07-30
Microphyt. (7/11/19). "Press Release: Microphyt Raises €28.5 Million to Develop Its Portfolio of Microalgae-based Natural Solutions for Nutrition and Well-being". Baillargues. 2019-07-11
next pagenext page 1 2 3 4 5 6 7 8 9 10 11  next pagenext page



Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px

» top